Ju S T, DeKruyff R H, Dorf M E
Cell Immunol. 1987 May;106(2):260-72. doi: 10.1016/0008-8749(87)90170-5.
After activation with specific antigen and antigen presenting cells (APC) L3T4+ inducer T-cell clones can lyse Ia+ APC. The present study characterizes the mechanism of activation and specificity of L3T4+ inducer cell-mediated cytolytic function. Two methods that bypass the physiological stimulus of antigen presented on Ia+ APC were used to activate L3T4+ clones. The first method utilized an antireceptor monoclonal antibody (MAb), KJ16.133, to activate KJ16.133+ clones. The activated clones expressed nonspecific cytolytic activity, killing target cells irrespective of their H-2 haplotype or their ability to express cell surface Ia molecules. The crosslinking of bound KJ16.133 antibody greatly enhanced cytolytic activity. This activation is receptor specific because KJ16.133- clones were not activated under identical conditions. The second method of activation was provided by a synergistic action of phorbol-12-myristate-13-acetate (PMA) and ionophore A23187. These agents nonspecifically activated all L3T4+ clones tested. The simultaneous presence of the two agents is required for maximal activation. Again, the activated clones expressed potent nonspecific cytolytic activity. These observations demonstrated that L3T4+ inducer T-cell-mediated killing can be separated into two stages: an activation step, which can be specifically and nonspecifically triggered and an effector phase which causes nonspecific lysis of bystander targets. The induction of nonspecific cytolytic activity by antireceptor MAb was inhibited by anti-L3T4 MAb (GK1.5). In contrast, activation of nonspecific cytolytic activity by treatment with PMA plus A23187 was not inhibited by anti-L3T4 MAb. Under the above activation conditions, antireceptor MAb selectively induced the secretion of IL-3 and expression of nonspecific cytolytic activity. However, there was little or no concomitant proliferation and production of IL-2. In contrast, activation by PMA plus A23187 coordinately induces expression of nonspecific cytolytic activity, secretion of lymphokines (IL-3 and IL-2), and cell proliferation. Thus, the anticlonotypic activation preferentially induces certain functions whereas activation with PMA plus A23187 is not selective.
用特异性抗原和抗原呈递细胞(APC)激活后,L3T4 +诱导性T细胞克隆可裂解Ia + APC。本研究对L3T4 +诱导性细胞介导的细胞溶解功能的激活机制和特异性进行了表征。使用两种绕过Ia + APC上呈递抗原的生理刺激的方法来激活L3T4 +克隆。第一种方法利用抗受体单克隆抗体(MAb)KJ16.133来激活KJ16.133 +克隆。活化的克隆表达非特异性细胞溶解活性,无论其H-2单倍型或表达细胞表面Ia分子的能力如何,均可杀伤靶细胞。结合的KJ16.133抗体的交联大大增强了细胞溶解活性。这种激活是受体特异性的,因为在相同条件下KJ16.133 -克隆未被激活。第二种激活方法是由佛波醇-12-肉豆蔻酸酯-13-乙酸酯(PMA)和离子载体A23187的协同作用提供的。这些试剂非特异性地激活了所有测试的L3T4 +克隆。两种试剂同时存在是最大激活所必需的。同样,活化的克隆表达出强大的非特异性细胞溶解活性。这些观察结果表明,L3T4 +诱导性T细胞介导的杀伤可分为两个阶段:一个激活步骤,可被特异性和非特异性触发;一个效应阶段,导致旁观者靶细胞的非特异性裂解。抗受体MAb诱导的非特异性细胞溶解活性被抗L3T4 MAb(GK1.5)抑制。相反,用PMA加A23187处理激活的非特异性细胞溶解活性不受抗L3T4 MAb抑制。在上述激活条件下,抗受体MAb选择性诱导IL-3的分泌和非特异性细胞溶解活性的表达。然而,几乎没有或没有伴随的增殖和IL-2的产生。相反,PMA加A23187的激活协同诱导非特异性细胞溶解活性的表达、淋巴因子(IL-3和IL-2)的分泌以及细胞增殖。因此,抗克隆型激活优先诱导某些功能,而用PMA加A23187激活则没有选择性。